Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial-Reference-Cited by-同舟云学术

Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial

Published:2015-08 Issue:6 Volume:25 Page:482-493
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Aman Michael¹,Rettiganti Mallikarjuna²,Nagaraja Haikady N.³,Hollway Jill A.¹,McCracken James⁴,McDougle Christopher J.⁵,Tierney Elaine⁶,Scahill Lawrence⁷,Arnold L. Eugene¹,Hellings Jessica¹,Posey David J.⁵,Swiezy Naomi B.⁵,Ghuman Jaswinder⁶,Grados Marco⁶,Shah Bhavik⁴,Vitiello Benedetto⁸

Affiliation:

1. Nisonger Center, Ohio State University, Columbus, Ohio.

2. Biostatistics Program, Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock, Arkansas.

3. Biostatistics, College of Public Health, Ohio State University, Columbus, Ohio.

4. Department of Psychiatry and Behavioral Sciences, David Geffen School of Medicine UCLA - Semel Institute, University of California, Los Angeles, California.

5. Department of Psychiatry, Indiana University School of Medicine, Indianapolis, Indiana.

6. Kennedy Krieger Institute, Baltimore Maryland.

7. Marcus Autism Center, Atlanta, Georgia.

8. National Institute of Mental Health, Bethesda, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2015.0005

Reference46 articles.

1. Acute and Long-Term Safety and Tolerability of Risperidone in Children with Autism

2. Medication Patterns in Patients with Autism: Temporal, Regional, and Demographic Influences

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Term Effectiveness of Off-Label Risperidone Treatment in Children and Adolescents: A Randomized, Placebo-Controlled Discontinuation Study;Journal of Child and Adolescent Psychopharmacology;2024-08-01

2. A Scoping Review of the Intersectionality of Autism and Intellectual and Developmental Disability with Social Inequity on Diagnosis and Treatment of Youth;Journal of Child and Adolescent Psychopharmacology;2024-07-03

3. Pharmacotherapy of Behavioral Symptoms and Psychiatric Comorbidities in Adolescents and Adults with Autism Spectrum Disorders;Adolescents and Adults with Autism Spectrum Disorders;2024

4. Eficácia de medicamentos utilizados no tratamento de sintomas do Transtorno do Espectro Autista: uma revisão sistemática com metánalise;Cuadernos de Educación y Desarrollo;2023-12-27

5. Case 16: Second-generation antipsychotics/mixed dopamine–serotonin receptor agonists (SGAs), side effects, and the autism spectrum: SGA-related side effects in a boy with autism spectrum disorder (ASD);Case Studies: Stahl's Essential Psychopharmacology;2023-11-09